CLINICAL_TRIALS
trial_result
· 2021-05-04
Clinical Trial Update: Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine [Phase 1, Phase 2]
Summary
Phase 1/2 trial updating reactogenicity, safety, and immunogenicity of the QazCovid-in COVID-19 vaccine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Research Institute for Biological Safety Problems | Conditions: Covid19, SARS-CoV Infection | Phase 1, Phase 2 | Status: COMPLETED